Accession Number: | 0001437749-22-019620 |
Date: | 2022-08-05 |
Issuer: | CARDIOVASCULAR SYSTEMS INC (CSII) |
Original Submission Date: |
POINTS JEFFREY S.
1225 OLD HIGHWAY 8 NW
ST. PAUL, MN 55112
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-08-05 | A | 18,916 | a | $0.00 | 128,228 | direct | ||
COMMON STOCK | 2022-08-05 | A | 56,747 | a | $0.00 | 184,975 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | restrictions lapse as to 6,306 shares on 8/13/23 and as to 6,605 shares on each of 8/13/24 and 8/13/25. |
f2 | subject to performance-based forfeiture of 28,374 shares based on the company's three-year total shareholder return for fiscal years 2023, 2024 and 2025 versus the company's peer group, and for 28,373 shares based on the company's average annual revenue growth in fiscal years 2023, 2024 and 2025. |